Forgotten, not neglected: Viral hepatitis in resource-limited settings, recall for action

Liver International

Volumn 34, Issue 1, 2014, Pages 12-15

  Lemoine, Maud ^a   Thursz, Mark ^b   Njie, Ramou ^a   Dusheiko, Geoffrey ^c  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^b ST MARY S HOSPITAL   (United Kingdom)

^c ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Access to treatment; Global health policy; Hepatocellular carcinoma; HIV AIDS resource limited countries; Viral hepatitis

Indexed keywords

ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; TENOFOVIR;

ANTIVIRAL THERAPY; ARTICLE; DELTA AGENT HEPATITIS; DRUG COST; HEALTH CARE POLICY; HEPATITIS; HEPATITIS B; HEPATITIS C; HEPATITIS VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER CELL CARCINOMA; MIXED INFECTION; POVERTY; VACCINATION;

ACCESS TO TREATMENT; GLOBAL HEALTH POLICY; HEPATOCELLULAR CARCINOMA; HIV/AIDS-RESOURCE-LIMITED COUNTRIES; VIRAL HEPATITIS;

ANTIVIRAL AGENTS; COOPERATIVE BEHAVIOR; DEVELOPING COUNTRIES; HEALTH CARE COSTS; HEALTH RESOURCES; HEALTH SERVICES ACCESSIBILITY; HEALTHCARE DISPARITIES; HEPATITIS, VIRAL, HUMAN; HUMANS; INTERNATIONAL COOPERATION; TREATMENT OUTCOME; VIRAL HEPATITIS VACCINES; WORLD HEALTH;

EID: 84890125269     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12283     Document Type: Article

References (22)

1. World Health Assembly. WHA63.18: viral hepatitis. Geneva, Switzerland: World Health Organization, 2010. Available at http://apps.who.int/gb/ebwha/pdf_files/WHA63/A63_R18-en.pdf. Accessed 12 June 2013.
2. Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006; 45: 529-38.
3. Joshi D, O'Grady J, Dieterich D, Gazzard B, Agarwal K. Increasing burden of liver disease in patients with HIV infection. Lancet 2011; 377: 1198-209.
4. Easterbrook P, Sands A, Harmanci H. Challenges and priorities in the management of HIV/HBV and HIV/HCV coinfection in resource-limited settings. Semin Liver Dis 2012; 32: 147-57.
5. Jemal A, Bray F, Forman D, et al. Cancer burden in Africa and opportunities for prevention. Cancer 2012; 118: 4372-84.
6. WHO. 2012, reported estimates of third dose of Hepatitis B vaccine per country. Available at http://apps.who.int/immunization_monitoring/globalsummary/timeseries/ts-coveragehepb3.html. Accessed 12 June 2013.
7. Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 2012; 30: 2212-9.
8. Chen HL, Lin LH, Hu FC, et al. Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV. Gastroenterology. 2012;142:773-81 e2.
9. Dusheiko G. Interruption of mother-to-infant transmission of hepatitis B: time to include selective antiviral prophylaxis? Lancet 2012; 379: 2019-21.
10. Thursz M, Njie R, Lemoine M. Hepatitis: global eradication of hepatitis B-feasible or fallacy? Nat Rev Gastroenterol Hepatol 2012; 9: 492-4.
11. WHO. Towards Universal Access. 2009. Available at http://www.who.int/hiv/pub/tuapr_2009_en.pdf. Accessed 2 September 2012.
12. Ford N, Calmy A. Improving first-line antiretroviral therapy in resource-limited settings. Curr Opin HIV AIDS 2010; 5: 38-47.
13. Lemoine M, Girard PM, Thursz M, Raguin G. In the shadow of HIV/AIDS: forgotten diseases in sub-Saharan Africa. Global health issues and funding agency responsibilities. J Public Health Policy 2012; 33: 430-8.
14. Kuhn R, Beall RF. The time for pharmaceutical compulsory licensing has expired. Nat Med 2012; 18: 1168.
15. Ford N, Kirby C, Singh K, et al. Chronic hepatitis C treatment outcomes in low- and middle-income countries: a systematic review and meta-analysis. Bull World Health Organ 2012; 90: 540-50.
16. Stiglitz J. Globalization and Its Discontents. Chapter 9 The Way Ahead; The Need for International Public Institutions. New York: W.W Norton & Company, 2002.
17. Piot P, Quinn TC. Response to the AIDS pandemic-a global health model. N Engl J Med 2013; 368: 2210-8.
18. Ford N, Singh K, Cooke GS, et al. Expanding access to treatment for hepatitis C in resource-limited settings: lessons from HIV/AIDS. Clin Infect Dis 2012; 54: 1465-72.
19. Piot P. No Time to Lose. A Life in Pursuit of Deadly Viruses. New York: WW Norton & Company, 2012.
20. Thursz M, Cooke GS, Hall AJ. Hepatitis B treatment in resource poor settings: time for action. Trop Med Int Health 2010; 15: 2-4.
21. WHO. http://www.who.int/csr/disease/hepatitis/GHP_framework.pdf. Accessed 2 September 2012.
22. Lemoine M, Njai HF, Shimakawa Y, et al. Rural and urban community-based screening for HBs antigen in the Gambia: assessment of chronic hepatitis B and proportion of eligible patients for antiviral therapy. J Hepatol 2013; 58(Suppl. 1): S402-3.